Reduced survival of rectal cancer patients with increased tumor epidermal growth factor receptor levels

Diseases of the Colon and Rectum

Volumn 46, Issue 10, 2003, Pages 1391-1399

  Kopp, Reinhard ^a   Rothbauer, Elisabeth ^a   Mueller, Elisabeth ^b   Schildberg, Friedrich Wilhelm ^a   Jauch, Karl Walter ^a   Pfeiffer, Andreas ^b  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

Colorectal cancer; Epidermal growth factor receptor

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; IODINE 125;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; INVASIVE CARCINOMA; ISOTOPE LABELING; LYMPH NODE METASTASIS; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PREDICTION; PROGNOSIS; RECTUM CARCINOMA; RECTUM MUCOSA; SIGNAL TRANSDUCTION; TUMOR GROWTH;

AGED; CARCINOMA; COLORECTAL NEOPLASMS; HUMANS; INTESTINAL MUCOSA; LYMPHATIC METASTASIS; NEOPLASM INVASIVENESS; PROGNOSIS; RADIOLIGAND ASSAY; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECTAL NEOPLASMS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 0142011609     PISSN: 00123706     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10350-004-6756-1     Document Type: Article

References (55)

1. Sporn MB, Roberts AB. Autocrine growth factors and cancer. Nature 1985;313:745-7.
2. Cohen S, Carpenter G, King L. Epidermal growth factor-receptor-protein kinase interactions. J Biol Chem 1980;258:4834-42.
3. Ullrich A, Schlessinger J. Signal transduction by receptors with tyrosine kinase activity. Cell 1990;61:203-12.
4. Tahara E. Genetic alterations in human gastrointestinal cancers. Cancer 1995;75:1410-7.
5. Downward J, Parker P, Waterfield MD. Autophosphorylation sites in the epidermal growth factor receptor. Nature 1985;311:483-5.
6. Carpenter G, Cohen S. Epidermal growth factor. Annu Rev Biochem 1979;48:193-216.
7. Schreiber AB, Libermann TA, Lax I, Yarden Y, Schlinger J. Biological role of epidermal growth factor-receptor clustering. J Biol Chem 1983;258:846-53.
8. Downward J, Yarden Y, Mayes E, et al. Close similarity of epidermal growth factor receptor and v-erb-B oncogen protein sequences. Nature 1984;307:521-7.
9. Malden LT, Novak U, Burgiss AW. Expression of transforming growth factor alpha messenger RNA in the normal and neoplastic gastro-intestinal tract. Int J Cancer 1989;43:380-4.
10. Tanaka S, Imanishi K, Yoshihara M, et al. Immunoreactive transforming growth factor alpha is commonly present in colorectal neoplasia. Am J Pathol 1991;139:123-9.
11. Coffey RJ, Shipley GD, Moses HL. Production of transforming growth factors by human colon cancer lines. Cancer Res 1986;46:1164-9.
12. Anzano MA, Riemann, D, Prichett W, Bowen-Pope DF, Greig R. Growth factor production by human colon carcinoma cells. Cancer Res 1989;49:2898-904.
13. Yasui W, Sumiyoshi H, Hata J, et al. Expression of epidermal growth factor in human gastric and colonic carcinomas. Cancer Res 1988;48:137-41.
14. Steele RJ, Kelly BE, Eremin O. Epidermal growth factor receptor expression in colorectal cancer. Br J Cancer 1990;77:1352-4.
15. Rothbauer E, Mann K, Wiebecke B, et al. Epidermal growth factor receptors and epidermal growth factor-like activity in colorectal mucosa, adenomas and carcinomas. Klin Wochenschr 1989;67:518-3.
16. Koenders PG, Peters WH, Wobbes T, Beex, LV, Nagengast FM, Benrad TJ. Epidermal growth factor receptor levels are lower in carcinomatous than normal colorectal tissue. Br J Cancer 1992;65:189-92.
17. Borlinghaus P, Wieser S, Lamerz R. Epidermal growth factor, transforming growth factor-a, and epidermal growth factor receptor content in normal and carcinomatous gastric and colonic tissue. Clin Invest 1993;71:903-7.
18. Mendelsohn J. Blockade of receptors for growth factors: an anticancer therapy. Clin Cancer Res 2000;6:747-53.
19. Baselga J. New therapeutic agents targeting the epidermal growth factor receptor. J Clin Oncol 2000;18(Suppl):54S-59S.
20. Ciardiello F, Tortora G. A novel approach in the treatment of cancer: targeting the epidermal growth factor receptor. Clin Cancer Res 2001;7:2958-70.
21. Pfeiffer A, Rothbauer E, Wiebecke B, Pratschke E, Kraemling HJ, Mann K. Increased epidermal growth factor receptors in gastric carcinomas. Gastroenterology 1990;98:961-7.
22. Munson PJ, Rodbard D. LIGAND: a versatile computerized approach for characterization of ligand-binding systems. Anal Biochem 1980;107:159-71.
23. Neal DE, Marsh C, Bennett MK, et al. Epidermal growth factor receptors in human bladder cancer: comparison of invasive and superficial tumors. Lancet 1985;1:366-8.
24. Sainsbury JR, Farndon JR, Sherbet GV, Harris AL. Epidermal growth-factor receptors and oestrogen receptors in human breast cancer. Lancet 1985;1:364-6.
25. Itakura Y, Sasano H, Shiga C, et al. Epidermal growth factor receptor overexpression in esophageal carcinoma. Cancer 1994;74:795-804.
26. Kopp R, Ruge M, Rothbauer E, et al. Impact of epidermal growth factor (EGF) radioreceptor analysis on long term survival of gastric cancer patients. Anticancer Res 2002;22:1161-8.
27. Koretz K, Schlag P, Möller P. Expression of epidermal growth factor in normal colorectal mucosa, adenoma and carcinoma. Virchows Arch A Pathol Anat 1990;416:343-9.
28. Maurer CA, Friess H, Kretschman B, et al. Increased expression of erbB3 in colorectal cancer is associated with concomitant increase in the level of erbB2. Hum Pathol 1998;29:771-7.
29. Higashiyama S, Abraham JA, Miller J, Fiddes JC, Klagsbrun M. A heparin-binding growth factor secreted by macrophage-like cells that is related to EGF. Science 1991;252:936-9.
30. Ullrich A, Coussens L, Hayflick JS, et al. Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells. Nature 1984;309:418-25.
31. Lemoine NR, Jain S, Silvestre F, et al. Amplification and overexpression of the EGF receptor and c-erbB-2 protooncogenes in human stomach cancer. Br J Cancer 1991;64:79-83.
32. Masui H, Wells A, Lazar CS, Rosenfeld MG, Gill GN. Enhanced tumorigenesis of NR6 cells which express non-down regulating epidermal growth factor receptors. Cancer Res 1991;51:6170-5.
33. Countaway JL, Northwood IC, Davis RJ. Mechanism of phosphorylation of the epidermal growth factor receptor at threonine 669. J Biol Chem 1989;264:10828-35.
34. Kopp R, Noelke B, Sauter G, Schildberg FW, Paumgartner G, Pfeiffer A. Altered protein kinase C activity in biopsies of human colonic adenomas and carcinomas. Cancer Res 1991;51:205-10.
35. Kusonoki M, Sakanoue Y, Hatada T, Yanagi H, Yamamura T, Utsunomiya J. Protein kinase C activity in human colonic adenoma and colorectal carcinoma. Cancer 1992;69:24-30.
36. Verstovsek G, Byrd A, Frey MR, et al. Colonocyte differentiation is associated with increased expression and altered distribution of protein kinase C isoenzymes. Gastroenterology 1998;115:75-85.
37. Emkey R, Kahn CR. Cross-talk between phorbol ester-mediated signaling and tyrosine kinase protooncogenes. I. Activation of protein kinase C stimulates tyrosine phosphorylation and activation of ErbB2 and ErbB3. J Biol Chem 1997;272:31172-81.
38. Chen N, Ma WY, She QB, et al. Transactivation of the epidermal growth factor receptor is involved in 12-O-tetradecanoylphorbol-13-acetate-induced signal transduction. J Biol Chem 2001;14:46722-8.
39. Maruvada P, Levine AE. Increased transforming growth factor-alpha levels in human colon carcinoma cell lines over-expressing protein kinase C. Int J Cancer 1999;80:72-7.
40. Odintsova E, Sugiura T, Berditchevski F. Attenuation of EGF receptor signalling by a metastasis suppressor, the tetraspanin CD82/KAI-1. Curr Biol 2000;10:1009-12.
41. Goldman R, Levy RB, Peles E, Yarden Y. Heterodimerization of the erbB-1 and erbB-2 receptors in human breast carcinoma cells: a mechanism for receptor transregulation. Biochemistry 1990;29:11024-8.
42. Gill N, Malik A, Potti A, Talukdar R, Saberi A, Mehdi SA. HER-2/neu overexpression in colonic malignancies. Gastroenterology 2002;122:248-9.
43. Venkateswarlu S, Dawson DM, St Clair P, Gupta A, Willson JK, Brattain MG. Autocrine heregulin generates growth factor independence and block apoptosis in colon cancer cells. Oncogene 2002;21:78-86.
44. Bos M, Mendelsohn J, Kim Y-M, et al. PD153035, a tyrosine kinase inhibitor, prevents epidermal growth factor receptor activation and inhibits growth of cancer cells in a receptor number-dependent manner. Clin Cancer Res 1997;3:2099-106.
45. Mendelsohn J. Epidermal growth factor receptor inhibition by a monoclonal antibody as anticancer therapy. Clin Cancer Res 1997;3:2703-7.
46. Karnes WE, Weller SG, Adjei PN, et al. Inhibition of epidermal growth factor receptor kinase induces protease-dependent apoptosis in human colon cancer cells. Gastroenterology 1998;114:930-9.
47. Partik G, Hochegger K, Schörkhuber M, Marian B. Inhibition of epidermal growth factor receptor dependent signalling by tyrphostins A25 and AG1478 blocks growth and induces apoptosis in colorectal tumor cells in vitro. J Cancer Res Clin Oncol 1999;125:379-88.
48. Jensen PJ, Rodeck U. Autocrine/paracrine regulation of keratinocyte urokinase plasminogen activator through the TGF-alpha/EGF receptor. J Cell Physiol 1993;155:333-9.
49. Lengyel E, Ried S, Heiss MM, Jaeger C, Schmitt M, Allgayer H. Ras regulation of urokinase-type plasminogen activator. Methods Enzymol 2001;333:105-16.
50. Ciardiello F, Caputo R, Bianco R, et al. Inhibition of growth factor production and angiogenesis in human cancer cells by ZD1839 (Iressa), a selective epidermal growth factor receptor tyrosine kinase inhibitor. Clin Cancer Res 2001;7:1459-65.
51. Gonzalez G, Crombet T, Catala M, et al. A novel cancer vaccine composed of human-recombinant epidermal growth factor linked to a carrier protein: report of a pilot clinical trial. Ann Oncol 1998;9:431-5.
52. Lammering G, Hewit TH, Hawkins WT, et al. Epidermal growth factor as a genetic therapy target for carcinoma cell radiosensitization. J Natl Cancer Inst 2001;93:921-9.
53. Huang SM, Harari PM. Modulation of radiation response after epidermal growth factor receptor blockade in squamous cell carcinomas: inhibition of damage repair, cell cycle kinetics, and tumor angiogenesis. Clin Cancer Res 2000;6:2166-74.
54. Camma C, Giunta M, Fiorica F, Pagliaro L, Craxi A, Cottone M. Preoperative radiotherapy for resectable rectal cancer. JAMA 2000;284:1008-15.
55. Kapiteijn E, Marijnen CA, Nategaal ID, et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 2001;345:638-46.